XIMEREX INC has a total of 12 patent applications. Its first patent ever was published in 1994. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, agriculture and biotechnology are OVAGEN INTERNAT LTD, CENTRAL INST FOR EXPERIMENTAL ANIMALS and DNX BIOTHERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Agriculture | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Animal care | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Beschorner William E | 10 |
#2 | Sosa Carlos E | 7 |
#3 | Thompson Scott C | 7 |
#4 | Kudlacek Patrick E | 2 |
#5 | Beschorner William | 2 |
Publication | Filing date | Title |
---|---|---|
WO2006113220A2 | Transgenic mammals expressing human preproinsulin | |
AU2003270728A1 | Growth of foreign cells in fetal animals facilitated by conditional and selective destruction of native host cells | |
EP0700297A1 | Surrogate tolerogenesis for the development of tolerance to xenografts |